The blood-derived biomarkers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are associated with CRC diagnosis and prognosis (Sun et al., 2018; Thomsen et al., 2018). The gene discussed is CEACAM5; the disease is colorectal carcinoma.